Aims: In adult population, the renal cell carcinoma (RCC) is one of the most common urological malignancies. It is meaningful to research for the molecular markers which are involved in the occurrence and development of RCC. Therefore, we concentrate on illuminating the role of microRNA-154-5p in progression of RCC and explore its prognostic values. Main methods: The real-time quantitative polymerase chain reaction (RT-qPCR) was applied to determine expression level of miR-154-5p in tissues. Afterwards, the transfected cell lines ACHN and 786-O were used for the CCK-8 assay, MTT assay, wound healing assay, transwell assay and flow cytometric assay to explore the role of miR-154-5p in regulating cellular function. In addition, formalin-fixed paraffin-embedded (FFPE) renal cancer samples were used for detecting the relationship between expression level of miR-154-5p and clinical information. Furthermore, univariate and multivariate Cox proportional-hazards regression analyses, and the Kaplan-Meier survival curves were performed to evaluate the prognostic value of miR-154-5p in RCC. Key findings: The RT-qPCR indicated that miR-154-5p is up-regulated in RCC pathologic specimens and cell lines. Results of study also demonstrated that upregulation of miR-154-5p reduced cell apoptosis and promoted cell proliferation, viability, migration as well as invasion in RCC cells. The prognosis analyses indicated that the expression level of miR-154-5p is associated with the prognosis of renal cancer, and the overall survival of patients with low expression is longer. Significance: The present study revealed that the oncogene miR-154-5p regulates cellular function and acts as a molecular marker with poor prognosis in renal cell carcinoma.
Introduction
Renal cell carcinoma (RCC) is considered as the most common malignant tumor in kidney, accounting for approximately 3% of all adult malignances [1] [2] [3] . There are five histological types of RCC, including clear cell RCC (65%), papillary RCC (15%), chromophobic RCC (1%) and collecting duct RCC (4%) and unclassified RCC(5%) [4] . In the past two decades, the incidence of RCC has increased gradually [5] . At present, up to 30% patients have suffered from cancer metastasis when they were primarily diagnosed with RCC [6] . In addition, approximately 20-40% RCC, which is localized, have metastasized distally after surgical treatment [7] . It could be said that RCC is still an extremely lethal disease, and timely detection and early diagnosis is extremely important for the treatment of RCC. Thus, it would be significant to illustrate the genesis and development of RCC and explore its potential molecular mechanisms.
In recent years, microRNA has been defined as the regulator and potential biomarker, playing a crucial part in oncogenesis, development and metastasis of RCC [8, 9] . As one kind of small non-coding RNAs, through attaching to the complementary sequences in mRNA transcripts, microRNA regulates the post-transcriptional expression of specific genes to repress the translation of functional from those https://doi.org/10.1016/j.lfs.2018.08.044 Received 17 April 2018; Received in revised form 11 August 2018; Accepted 19 August 2018 transcripts, even cause their degradation [10] [11] [12] . Thus, MircroRNA might function as a molecular marker of RCC on early diagnosis, prognosis prediction and targeted treatment.
Previous research have revealed that miR-154-5p have dysregulated expression in many tumors of different organs and tissues, such as prostate cancer [13] , colorectal cancer [14] and hepatocellular carcinoma [15] . Nevertheless, to the best of our knowledge, there is still no relevant research in the kidney. Therefore, the present study systematically describes the function of miR-154-5p in RCC to investigate the roles of miR-154-5p in renal carcinogenesis. Furthermore, univariate and multivariate Cox proportional-hazards regression analysis, and the Kaplan-Meier survival curves were performed to predict the prognostic value of miR-154-5p in renal cell carcinoma.
Materials and methods

Human specimens and cell lines
All human pathologic specimens of Renal cell carcinoma (RCC) were collected and stored at −80°C in RNAlater (Qiagen, Valencia, CA, USA) after permitted by Peking University Shenzhen Hospital Ethical Committee (Shenzhen, China). On the basic of the 2010 American Joint Committee on Cancer staging system (AJCC), all RCC tissues were classified,and results are given in the Table 1 .
Paraffin specimens of renal carcinoma
All Formalin-fixed paraffin-embedded (FFPE) specimens of renal carcinoma were provided by the Peking University Shenzhen Hospital. As shown in Table 2 , the clinicopathological characteristics were analyzed on the basis of the 2010 AJCC. The miRNeasy FFPE Kit (Qiagen) was used for extracting RNA from paraffin specimens.
RNA extraction, reverse transcription and RT-qPCR
With the use of TRIzol Reagent (Invitrogen; Thermo Fisher Scientific, Inc.), total RNA was extracted, and refined by using the RNeasy Maxi kit (Qiagen GmbH). Subsequently, with the purpose of determining the expression of miR-154-5p, the qPCR was applied to reverse transcription using the miScript Reverse Transcription kit (Qiagen GmbH) in Roche Lightcycler 480 Real Time PCR system (Roche Diagnostics, Basel, Switzerland). The expression levels of miR-154-5p in pathologic specimens and cell lines were normalized to the expression levels of internal control U6.2-ΔΔCq method was the analytical method used in the study [16] . The primer sequences can be seen in Table 3 .
Cell culture and transfection
ACHN and 786-O cell lines, were respectively raised with Dulbecco's modified Eagle's medium (DMEM; Gibco; Thermo Fisher Scientific Inc. Waltham, MA, USA) and Roswell Park Memorial Institute 1640 medium (Gibco), both them mixed together with 10% fetal bovine serum (Gibco), 1% antibiotics (penicillin, 100 μ/ml; streptomycin sulfates, 100 mg/ml) and 1% glutamate (Gibco). And then, all RCC cells were cultured in a humidified chamber at 37°C and with 5% CO2. For preparation of transfection reagents, mimics and inhibitor, artificially synthesized by GenePharma Inc. (Shanghai, China), were mixed with Lipofectamine 2000 (Invitrogen Life Technologies) and added into Opti-MEM I Reduced Serum medium (Gibco, Thermo Fisher Scientific, Inc.). After that, RT-qPCR was performed to evaluate the expression of miR-154-5p and the transfection efficiency.
Cell proliferation assay
The ability of cell proliferation in cells were assessed with the Cell Counting Kit-8 (CCK-8) assay. About miR, microRNA; NC, negative control; PCR, polymerase chain reaction.
Cell activity test
The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was performed to evaluate the viability of RCC cells. Approximately 5 × 10 3 RCC cells were seeded into 96-well plates and after 24 h, all of them were respectively transfected. After cultured 4 days later, the RCC cells were hatched with 20 μl MTT solution (5 mg/ ml; Sigma-Aldrich, St Louis, MO, USA) for 4 h, and then, the mixed solution was exchanged with 100 μl dimethylsulfoxide (DMSO, SigmaAldrich; Shanghai, China). Subsequently, the new mixed medium was agitated on the reciprocating decolorization shaking table (TSB-108, Qilinbeier, Jiangsu, China) for 15 min at room temperature. Finally, with the use of ELISA microplate reader (Bio-Rad, Hercules, CA, USA) at the wavelength of 490 nm, the optical density (OD) was measured to evaluate the viability of RCC cells.
Cell wound healing assay
In this assay, about 5 × 10 3 RCC cells were seeded into 6-well plates. After 24 h, all of them were respectively transfected with miR-154-5p mimics, inhibitors and the corresponding negative control. After 6 hours transfection, a clear straight line in each well was made with a sterile 1000 μl pipette tip through scraping the cell monolayers carefully and evenly. All the floating cells were cleaned up by Phosphate Buffered Saline (PBS; Gibco). Subsequently, RCC cells in 6-well plates were cultured with serum-free DMEM continually. Images of the scratches 0 h, 12 h after were captured with a digital camera system (Olympus Corporation, Tokyo, Japan).
Transwell migration and invasion assays
The ability of migration and invasion of the renal cancer cells were evaluated by the transwell assay. In this assay, about 1 × 10 4 RCC cells, transfected with mimics, inhibitors and negative control, were seeded into the upper chamber of the insert with serum-free DMEM. On the contrary, the bottom of the insert was filled with medium containing 10% serum. Subsequently, the migration of RCC cells lasted 24 h, and invasion was 48 h. And then, the cells, located at the bottom of the inserts, were fixed with paraformaldehyde. After 25 min, fixed cells were stained with crystal violet. Finally, the number of cells was calculated by using the microscope.
Flow cytometric assay
The flow cytometric assay was performed to analyze the early cell apoptosis rate of RCC cells. About 3 × 10 5 RCC cells were seeded and cultured in 6-well plates. Cells were respectively transfected with miR-154-5p mimics, inhibitors and negative control 24 h later. After hatched for 48 h, transfected cells were collected and washed using cold PBS. Subsequently, those cells, which have been resuspended in 100 μl 1× binding buffer, were stained by 5 μl Annexin V-fluorescein isothiocyanate (Invitrogen; Thermo Fisher Scientific, Inc.) and 5 μl propidium iodide (Invitrogen; Thermo Fisher Scientific, Inc.). After that, the cells were incubated away from light at room temperature for 15 min. In the end, after addition of 400 μl binding buffer every flow tube, the flow cytometry (EPICS Xl-4, Beckman Coulter, Brea, CA, USA) was performed to analyze the early apoptosis rate of RCC.
Statistical analysis
In the present study, statistical analysis depends on the SPSS 19.0 statistical software package (IBM SPSS, Armonk, NY, USA). Statistical significance was confirmed by the Student's t-test. With the use of Paired t-test, expression level of miR-154-5p was analyzed. In order to 
Pearson Chi-square test were performed. Univariate and multivariate Cox proportional-hazards regression analysis, and the Kaplan-Meier survival curves were performed to predict the prognostic value of miR-154-5p in renal cell carcinoma. Afterwards, the differences between these curves were evaluated by the use of log-rank test. P < 0.05 suggests a statistically significant difference.
Results
miR-154-5p is upregulated in RCC tissues and cell lines
In the present study, relative expression of miR-154-5p has been shown in Fig. 1A . The result revealed that expression of miR-154-5p in RCC was significantly higher than the corresponding normal tissues (P < 0.05), as shown in Fig. 1B . The data of miR-154-5p expression quantity in cell lines in accordance with results in tissues, revealed that expression of miR-154-5p in ACNH and 786-O cells was higher than 293 T (P < 0.05), as shown in Fig. 1C. 
Cell transfection efficiency
Results of RT-qPCR (Fig. 1D ) revealed that the relative expression level of miR-154-5p in ACHN cells transfected with miR-154-5p mimics and inhibitors are 414.91 times and 12.94% compared with corresponding negative control respectively. Similar outcome was got in 786-O cell line, in which the results are 493.418 and 36.10%.
miR-154-5p promotes RCC cell proliferation
For RCC cells (ACHN and 786-O), the experiment results suggested that up-regulation of miR-154-5p strengthened cell proliferation. ACHN cells, transfected with mimics, cell proliferation was risen by 13.28% (P < 0.05), 27.16% (P < 0.05), and 30.11% (P < 0.05) ( Fig. 2A) , while in cells transfected with inhibitor, proliferation was declined by 12.37% (P < 0.05), 20.14% (P < 0.05) and 22.66% (P < 0.05) (Fig. 2B ) at 24, 48 and 72 h after transfection, respectively. And for 786-O cells, transfected with mimics, cell proliferation was increased by 14.73% (P < 0.05), 12.42% (P < 0.01) and 16.72% (P < 0.05) (Fig. 2C) , on the contrary in cells transfected with inhibitor, proliferation was decreased by 10.05% (P < 0.05), 14.37% (P < 0.05) and 20.82% (P < 0.05) (Fig. 2D) at 24, 48 and 72 h after transfected. The results of CCK-8 assay revealed that miR-154-5p could strengthen the ability of proliferation in RCC. 
miR-154-5p promotes RCC cell viability
The results shown in Fig. 3 revealed that high expression of miR-154-5p increased cell survivability. For ACHN cells, transfected with mimics, cell survivability was risen by 38.74% (P < 0.05), while in cells transfected with inhibitor, it was declined by 20.56% (P < 0.05). And for 786-O cells, transfected with mimics, cell survivability was increased by 27.99% (P < 0.05), while in cells transfected with inhibitor, it was decreased by 17.85% (P < 0.05).
miR-154-5p promotes RCC cell mobility
In the wound scratch assay, as presented in Fig. 4 , results showed that migration distance of ACHN cells was increased by 78.06% (P < 0.05) in mimic group, nevertheless, it was reduced by 50.58% (P < 0.05) in inhibitor group. Similar results was obtained in 786-O cells, showed that in miR-154-5p mimic group, migration distance was risen by 40.20% (P < 0.05) while in inhibitor group, migration distance was declined by 44.82 (P < 0.05).
As for the transwell assay, the results revealed that high expression of miR-154-5p conduces to cell migration and invasion. As we can see in Fig. 5 , the number of ACHN cell transfected with mimics migrated or invaded to the bottom was risen by 100.20% (P < 0.05) and 87.74% (P < 0.05). On the contrary, ACHN cells were reduced by 47.58% (P < 0.05) and 44.89% (P < 0.05) in migration and invasion respectively. For 786-O cells, the number of cell transfected with miR-154-5p mimics migrated or invaded to the bottom was risen by 52.36% (P < 0.05) and 67.60% (P < 0.05), while transfected with inhibitor was declined by 54.70% (P < 0.05) and 54.80% (P < 0.05). The results imply that miR-154-5p promotes RCC cell mobility.
miR-154-5p inhibits RCC cell apoptosis
This assay revealed that early apoptosis rate in ACHN cells, transfected with mimic, was 14.43%, apparently lower than negative control 19.53% (P < 0.05; Fig. 6A ), while transfected with inhibitor was 23.6%, significantly higher than negative control 17.83% (P < 0.05; Fig. 6B) . Likewise, the result of flow cytometry in 786-O approve of miR-154-5p as the inhibition molecular in RCC cell apoptosis. 786-O cells, transfected with mimic and negative control were 13.67% and 18.47% (P < 0.05; Fig. 7A ), respectively. Apoptosis in cells transfected with inhibitor and negative control were respectively 23.07% and 16.83% (P < 0.05; Fig. 7B ). Above data indicate that miR-154-5p inhibits RCC cell apoptosis.
MiR-154-5p is an important prognostic molecular marker of RCC
It could be seen in Table 3 that the expression level of miR-154-5p has no significant difference in gender, age, stage and tumor size. In univariate analysis, it is easy to find that patients with high expression level of miR-154-5p have a lower overall survival (HR = 0.201, 95% CI = 0.043-0.929, P = 0.040, Table 4 ), and the survivorship curve was shown in Fig. 8 .A. The same result could be obtained in multivariate analysis (HR = 0.195, 95% CI = 0.039-0.970, P = 0.046, Table 4 ), and the survivorship curve was shown in Fig. 8 .B. In addition, the KaplanMeier survival analysis also drew the same conclusion (shown in Fig. 9 ) that patients whose total overall survival is longer have lower expression level of miR-154-5p. Results indicated that the expression level of miR-154-5p is associated with the prognosis of renal cancer, and the overall survival of patients with low expression is longer. In summary, miR-154-5p might be a potential and important molecular marker for predicting prognosis of RCC. 
Discussion
The genesis and development of RCC are related to various factors, such as environmental factors and carcinogenic substance [17, 18] . Clinical manifestations of RCC are nonspecific with flank pain, flank mass, or hematuria being the most common presentation [19] . Because of chemotherapy and radiation therapy resistance and restricted utility of surgical treatment of RCC, palliative care remains the main therapeutic method accepted by advanced cancer patient [4] . Therefore, it's obligated find the breakthrough point for RCC treatment.
MicroRNAs are reported to be involved in numerous cellular processes [20] . Burgeoning evidence has emphasized the importance of miRNAs in post-transcriptional regulation of the genesis and development of RCC and other types of cancers. For example, results of Fan et al. [21] , revealed that the increased miR-122 levels plays a role in RCC cells migration and invasion.
Abundant literatures demonstrated that miR-154-5p plays a significant role in the genesis and development of other types of cancers. In glioblastoma, overexpression of miR-154-5p has inhibited utility for cell proliferation and metastasis by binding to the 3′-UTR of PIWIL1 [22] . Result of Xin et al. [23] revealed that by targeting RSF1 and RUNX2, miR-154 works as an anti-oncogene in bladder cancer. In addition, overexpression of miR-154 and downregulation of its target E2F5 are responsible for the inhibition of cell growth and invasion, suggesting miR-154 serving as a latent therapeutic target for treating breast cancer [24] .
Abundant literatures demonstrated that miR-154-5p is compactly connected with other diseases. MiR-154 was found to be downregulated in Graves' disease (GD) patients while it returns to normal in GD patients in remission. It suggested that miR-154 might be a biomarker of GD [25] . Another study revealed that overexpression of miR-154 and low expression of its target Dickkopf-related protein 2 (DKK2) contribute to the activation of cardiac fibroblasts [26] .
At present, lots of studies have revealed the important role of miR-154-5p in tumors occurrence and progress. However, the role of miR-154-5p in RCC remains to be elucidated. The researches mentioned above have indicated that miR-154-5p was involved in regulation of cancers as a suppressor, whereas the present study discovered that miR-154-5p function as an oncogene in RCC. It suggested that compared with kinds of other cancers, the potential carcinogenetic mechanism of miR-154-5p in RCC is undefined and different. In the present study, RTqPCR indicated that miR-154-5p is up-regulated in RCC pathologic specimens and cell lines. Results of study also demonstrated that upregulation of miR-154-5p reduced cell apoptosis and promoted cell proliferation, migration as well as invasion in RCC cells. The results indicated that miR-154-5p function as an oncogene in RCC, which is different from the role of miR-154-5p in other types of cancer. However, the limitation of present study is that the potential molecular mechanism of miR-154-5p in RCC has not been clarified completely, which need further elucidation. In addition, the role of miR-154-5p as a molecular marker would be the priority for further research.
The present study revealed that miR-154-5p is involved in cell proliferation, migration, invasion, apoptosis in RCC and functions as an oncogene. In addition, miR-154-5p may be served as a molecular marker for early detection, postoperative monitoring recurrence, even targeted therapy in the future. Fig. 9 . The Kaplan-Meier survival analysis drew a conclusion that patients whose total overall survival is longer have lower expression level of miR-154-5p.
